What is the current stock price of Cardio Diagnostics Holdings, Inc. (CDIO)?

As of the latest market data, Cardio Diagnostics Holdings, Inc. (CDIO) is trading at $1.79. The stock has seen a gain of 1.13% today.

Does Cardio Diagnostics Holdings, Inc. (CDIO) pay a dividend?

Based on current data, Cardio Diagnostics Holdings, Inc. does not have a confirmed active dividend policy.

What is the market cap of Cardio Diagnostics Holdings, Inc.?

The current market capitalization of Cardio Diagnostics Holdings, Inc. (CDIO) is approximately unavailable.

CDIO

Cardio Diagnostics Holdings, Inc.·Healthcare

1.79

1.130%(+0.02)

Market Open

Last Updated: — ET

52W L: $0.9752W H: $7.91

CDIO NEWS

businesswire.com

5h ago

Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will exhibit at four upcoming national benefits conferences.

globenewswire.com

May 20

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Meesha Dogan, CEO of Cardio Diagnostics Holdings Inc.

AUSTIN, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels.

Company Profile

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2022-01-14

Beta

2.26

Websitecardiodiagnosticsinc.com↗